Google Ads Healthcare Policy in 2026: Rx Ads Reach AI Mode — What Nutra and Telehealth Can Still Run

The Google Ads healthcare policy just got a new place to apply. In October 2026, Google started testing prescription drug ads in AI Mode and AI Overviews in the US. The rules did not loosen, though. Certification, restricted drug terms and the ban on unapproved substances all still apply. Only the surface is new.

This guide is for media buyers who run health, nutra and telehealth offers. You will see what Google actually confirmed, how the policy is built, and which statistics matter. After that, there is an illustrative case, a working setup and an FAQ.

What changed in the Google Ads healthcare policy: Rx ads enter AI Mode

The story has two steps. First, on June 2, 2026, Google Ads Liaison Ginny Marvin confirmed a small test of healthcare ads in AI Mode. It covered US advertisers and English queries only. Eligible campaign types were Performance Max, AI Max with search term matching, Shopping and broad match. The same types could also serve in AI Overviews.

That first phase had a creative limit. Ads with pinned assets or text disclaimers could not join. As a result, many regulated advertisers stayed out.

Second, in October 2026, Google confirmed to Adweek that the test now includes certain pharmaceutical products. In other words, branded prescription drugs can appear in AI Mode and AI Overviews. However, they run only as standard text and Shopping ads in sections labeled “Sponsored.” Google also keeps them out of experimental formats where AI rewrites the ad copy.

The first Rx ad spotted in AI Mode

Adthena captured the first prescription drug ad inside an AI Mode answer on October 11, 2026. Eli Lilly promoted an oral GLP-1 weight loss pill on the query “glp-1 medication.” Interestingly, the copy never named the drug. Instead, it was a help-seeking ad that nudged people to ask their doctor.

There is one more catch. Google Ads has no report that separates AI Mode or AI Overview placements from regular search. So you can be live in the test and still not know which questions your ad answered.

Negative keywords still matter in AI answers

Google has told advertisers that negative keywords still apply in AI Mode. However, people phrase questions very differently there. They write long, detailed prompts instead of two-word queries. As a result, old negative lists may block questions you want, or miss ones you should exclude. One media buyer told Adweek that lists will need to become more extensive. So review your negatives for health campaigns before you widen match types.

How the Google Ads healthcare policy is built

The official Healthcare and medicines policy is a set of sub-policies. Some content can’t run at all. Other content can run only in certain countries and only after certification. In that case, the ad usually gets the “Eligible (limited)” status.

Prescription drug services

Online pharmacies and telemedicine providers must apply before they can advertise. Rules differ by country, so check the location table for every geo you target. In April 2026, Google opened telemedicine in New Zealand and certified online pharmacies in India. Then, in August, it added telemedicine in Spain. In each case, advertisers need LegitScript certification plus Google certification, and in India and Spain they still can’t promote prescription drugs in ads or on landing pages.

Restricted drug terms

Google restricts prescription drug names in ads, keywords and landing pages. Depending on the country, certified advertisers may use them. For everyone else, a drug name in a headline or keyword is a fast disapproval.

Pharmaceutical manufacturers

Drugmakers can advertise prescription and over-the-counter medicines in select locations only. In addition, they must be certified by Google. This is the group that the AI Mode Rx test is built around.

Unauthorized pharmacies: the hardest line in the Google Ads healthcare policy

This is the red line. Selling prescription drugs without a prescription, or targeting places where you hold no license, is not allowed. Google treats it as an egregious violation. That means account suspension on detection, without warning, and no return to Google Ads. Appeals succeed only in compelling cases.

Unapproved substances

Google bans some products regardless of claims of legality. The list includes items on its non-exhaustive list of unapproved pharmaceuticals and supplements. It also covers products with ephedra and hCG sold for weight loss. This sub-policy hits nutra harder than any other.

Other sub-policies cover addiction services, clinical trials, cell and gene therapies, birth control, HIV home tests and health insurance. Each has its own country table.

Statistics: the Google Ads healthcare policy in numbers

Here are the figures worth knowing before you plan a health campaign. Every number has a public source.

• In 2025, Google blocked or removed more than 87.8 million ads under Healthcare and medicines. It also restricted more than 119.3 million more (Google 2025 Ads Safety Report, published April 16, 2026).
• Overall, Google blocked or removed 8.3 billion ads and suspended 24.9 million advertiser accounts in 2025. It stopped over 99% of bad ads before they served.
• Healthcare has more restricted ads than blocked ones. So the typical outcome is a limited reach, not a ban.
• Across 50,000 US AI Mode ad placements tracked in August 2026, prescription brands had zero (Adthena).
• AI Overviews appear for 75% of pharma-related keywords (Eversana, May 2026, cited by eMarketer).
• 40% of people who use AI for health queries research medications, the second most common use (eMarketer Digital Health survey, January 2026).
• 18% of AI health users changed their medications after using a chatbot (Rock Health, March 2026, cited by eMarketer).
• Search will take about 56% of US healthcare and pharma digital ad spend in 2026. That is nearly $18 billion, up 19.5% year over year (eMarketer forecast).

What does this mean for affiliates? First, AI answers now sit in the decision path for health searches. Second, big pharma brands will fill this space first, because they already hold certifications. Third, the cost of a policy mistake stays the same, whatever the surface.

Where nutra fits in the Google Ads healthcare policy

Most affiliate health offers are not prescription drugs. Instead, they are supplements, creams, gummies and devices. Even so, the Google Ads healthcare policy still shapes what you can run. Several rules overlap here.

Ingredients come first

Before you write a single headline, check the composition. If a product contains an unapproved substance, no landing page will save it. Moreover, a ban for this reason often spreads to linked accounts.

Claims are a separate risk

Promises like “lose 10 kg in a week” or “cures diabetes” fall under misrepresentation. That is a different policy, but it fires on the same pages. Likewise, fake doctor endorsements and fake news layouts trigger it fast.

GLP-1 is a minefield

GLP-1 searches are exactly where pharma brands now show up in AI Mode. Meanwhile, many affiliate offers borrow the term for supplements. However, drug names are restricted terms. So “natural Ozempic” or a semaglutide keyword is a quick way to get disapproved. For a non-drug product, use neutral wording about appetite, routine or wellness instead.

AI rewrites do not help regulated copy

Google keeps Rx ads out of formats where AI rewrites the text. For your own health campaigns, apply the same logic. Turn off text customization and keep pinned, reviewed copy. Otherwise, the system may generate a claim you never approved.

Case study: the Google Ads healthcare policy and a US joint supplement (illustrative)

This is a composite example, not a client report. The numbers are hypothetical and only show the logic of the fixes.

Starting point. The offer was a joint-support supplement with a free-trial funnel. The geo was the US. The buyer launched a Performance Max campaign with text customization on. The landing page showed a “doctor” in a white coat and the line “replaces painkillers.”

What went wrong. Within two days, several assets were disapproved for misrepresentation. In addition, AI-written headlines added “clinically proven,” which the brand could not support. The account got a warning, and spend stopped.

What the buyer changed. First, they checked every ingredient against Google’s unapproved substances list. Next, they removed the fake doctor and the painkiller comparison. Then, they moved to a Search campaign with pinned, reviewed headlines. Finally, they turned off text customization and final URL expansion.

Outcome. After review, the ads ran again with a narrower but stable reach. In this hypothetical, the cost per lead rose a little, yet the account stayed alive. That is the real win in this vertical.

Real setup for health offers under the Google Ads healthcare policy

Here is a setup we see working for compliant nutra and wellness offers. Adjust it to your geo and product.

• Offer: a supplement or device with a clean, documented ingredient list. No drug claims.
• Geo: US, UK, Canada or Australia for Tier-1. Check the country table first.
• Account: an agency account with history, verified payments and advertiser verification done.
• Campaign type: Search with exact and phrase match. Add Performance Max only after the first two weeks.
• Keywords: problem and routine terms, such as “joint stiffness morning routine.” Avoid drug names.
• Negatives: every drug name, “prescription,” “without prescription,” and “cure.”
• Creative: pinned, reviewed RSA headlines. Text customization and auto-generated assets off.
• Landing page: a real brand page with ingredients, sources, contact details and a refund policy.
• Budget: start at $50 to $100 a day per geo. Avoid big edits during the first week of learning.
• Conversion goal: a confirmed order or a qualified lead, not a button click.

Before launch, review the page against our guide to Google Ads destination requirements. In addition, read our breakdown of advertising in Google AI Mode to see how ads reach Gemini answers.

Google Ads healthcare policy checklist before launch

1. Every ingredient is checked against the unapproved substances list.
2. No prescription drug names in ads, keywords or the landing page.
3. No disease cure claims or before-and-after promises.
4. No fake doctors, fake reviews or fake news layouts.
5. Text customization and auto assets are off.
6. The landing page shows the company, contacts and a refund policy.
7. Each geo is checked in the country table of the policy.
8. Certification is in place if you run telemedicine or pharmacy offers.

If an ad still gets rejected, read the exact reason before you appeal. Our post on the Google Ads Policy Manager and appeals shows how. Certification also works the same way in other regulated niches. For example, see our guides on financial services verification and prediction market ads.

Where PPC Rebels agency accounts fit

Health and nutra are high-risk niches. Fresh accounts there often hit reviews before they collect any data. That is why PPC Rebels provides agency Google Ads accounts for high-risk verticals. We also help with verification, policy checks and disapproval analysis.

Tools for your setup, such as trackers, proxies and anti-detect browsers, are in our services directory. And if you run a service for media buyers, see our advertising page.

FAQ: Google Ads healthcare policy

Can any health advertiser now appear in AI Mode?

No. The test is limited to the US, and Rx ads run only as standard text and Shopping ads. Existing certifications still apply.

Did Google relax the healthcare policy in October 2026?

No. Google opened a new surface for certain pharmaceutical products. The Healthcare and medicines rules stayed the same.

Can I see whether my ads served in AI Mode?

Not in Google Ads today. There is no report that splits AI Mode or AI Overview placements from regular search.

Can I use drug names like semaglutide in keywords?

Only if you are certified and the country allows it. Otherwise, restricted drug terms lead to disapprovals.

Do supplements need certification?

Usually not. However, they must avoid unapproved substances and misleading health claims, or ads will be disapproved.

What gets an account banned without warning?

Unauthorized pharmacy activity, such as selling prescription drugs without a prescription. Google treats it as egregious.

Which countries opened up in 2026?

New Zealand (telemedicine) and India (online pharmacies) in April, then Spain (telemedicine) in August. LegitScript and Google certification are required.

Bottom line

The Google Ads healthcare policy did not get softer in 2026. Instead, it now covers a new surface where AI answers meet health questions. So clean up ingredients, claims and copy first. Then pick the right geo and certification. With a stable agency account from PPC Rebels, a compliant health setup gets the time it needs to scale.